| アブストラクト | PURPOSE: The aim of this study was to characterize the frequency of adverse effects where delta-8 tetrahydrocannabinol (D8-THC) was identified as a possible suspect drug in the FDA Adverse Event Reporting System (FAERS) database. METHODS: A case-series design was used. RESULTS: A total of 183 cases listed D8-THC as a suspect drug in FAERS as of June 30, 2021. The most common events included dyspnea, respiratory disorder, and seizure. The reporting odds ratios were consistently and significantly greater than 2, a 2-fold increase from 2019 to 2021, indicating a potential safety signal. CONCLUSION: The first report of D8-THC, in the FAERS database, as a suspect drug appears to be in 2011. Overall, there are 183 total cases listing D8-THC as a suspect drug in the FAERS database as of June 30, 2021. Of the 183 cases, most were respiratory in nature. |
|---|
| ジャーナル名 | Drug, healthcare and patient safety |
|---|
| Pubmed追加日 | 2023/2/7 |
|---|
| 投稿者 | Simon, Teresa A; Simon, John H; Heaning, Erin G; Gomez-Caminero, Andres; Marcu, Jahan P |
|---|
| 組織名 | Physicians Research Center, LLC, Toms River, NJ, USA.;Marcu Enterprises, Jersey City, NJ, USA. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/36742440/ |
|---|
